Our Management Team
Pherin Pharmaceuticals, Inc. is presently operating under the leadership of a small management team with significant experience in the life sciences industry. Our management team has access to some experts in the fields of pharmaceutical research and development, drug discovery and regulatory affairs. We also have a diversified scientific advisory board comprising world-renowned scientists.
Toby Rosenblatt has served as a member of the Board of Directors since 1992, became Chairman of the Board of Directors in July 2018 and was made Executive Chairman in September of 2020. Mr. Rosenblatt is President of Founders Investments Ltd, a private investment firm. He has served as a director of several small businesses in the fields of financial services and biotechnology as well as a director of several BlackRock mutual funds. Mr. Rosenblatt serves on the boards of several charitable foundations and nonprofits serving healthcare and education. Mr. Rosenblatt holds a BA degree from Yale University and an MBA degree from Stanford University.
Kevin McCarthy has served as Director of the Company since our founding in 1991 and became our Treasurer, Secretary and CFO in 2018. Mr. McCarthy also served as Senior Vice President and Chief Financial Officer from August 1991 until 2001. Prior to becoming an officer of the Company in 2018, Mr. McCarthy was Executive Vice President of Shasta Crystals, a materials science company developing crystalline materials for high power military grade lasers, industrial lasers and medical lasers. Mr. McCarthy holds a B.S. degree from San Francisco State University and an MBA degree from California State University, Chico.